CTRI/2018/09/015643尚未招募3 期
CONcurrent versus SEQuential Chemo-Endocrine therapy in ER positive and HER2 negative non-metastatic breast cancer (CONSEQuenCE) - CONSEQuenCE
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Non-metastatic, biopsy proven breast cancer
- •2.ER and/or PR positive
- •3.HER2 negative
- •4.Age > 18 yrs
- •5.Fit to receive chemotherapy
- •6.Written, informed consent
- •7.Planned to receive both chemo and endocrine therapy in the adjuvant or neo-adjuvant setting
排除标准
- •1.Pregnant or lactating women
- •2.Patients who are candidates to receive only endocrine treatment (low risk of recurrence)
- •3.Inflammatory breast carcinoma
- •4.Women who have received prior chemo/hormonal therapy for breast cancer
- •5.Co-existing non-breast malignancy (such as hematolymphoid/ovarian cancer)
研究者
相似试验
尚未招募
1 期
Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer PatientsFemale Breast CancerNCT05755581Sohag University100
进行中（未招募）
不适用
The CORE Study (Chemotherapy or Endocrine Treatment first?) - COREEUCTR2005-000986-20-DETechnical University of Munich1,500
已完成
2 期
Chemotherapy and Radiotherapy, given either together or sequentially, before surgery followed by surgery in operable cancer of gallbladder patients: A pilot studyCTRI/2011/12/002264All India Institute of Medical Sciences16
已完成
4 期
Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)Early-stage Breast CancerNCT03948568Ottawa Hospital Research Institute262
招募中
2 期
The efficacy and safety of concurrent chemoradiotherapy for squamous cell carcinoma of the vulva. Phase II StudyVulva cancerJPRN-UMIN000013439TGCU(Tohoku Gynecological Cancer Unit)40